Journal of Radiation and Cancer Research

REVIEW ARTICLE
Year
: 2018  |  Volume : 9  |  Issue : 4  |  Page : 132--146

Acute radiation syndrome: An update on biomarkers for radiation injury


Vijay K Singh1, Paola T Santiago1, Madison Simas1, Melissa Garcia1, Oluseyi O Fatanmi1, Stephen Y Wise1, Thomas M Seed2 
1 Department of Pharmacology and Molecular Therapeutics, Division of Radioprotectants, F. Edward Hébert School of Medicine, Uniformed Services University of the Health Sciences; Department of Scientific Research, Armed Forces Radiobiology Research Institute, Uniformed Services University of the Health Sciences, Bethesda, MD, USA
2 Tech Micro Services, 4417 Maple Avenue, Bethesda, MD, USA

Correspondence Address:
Vijay K Singh
Department of Pharmacology and Molecular Therapeutics, Division of Radioprotectants, F. Edward Hébert School of Medicine, Uniformed Services University of the Health Sciences; Department of Scientific Research, Armed Forces Radiobiology Research Institute, Uniformed Services University of the Health Sciences, Bethesda, MD
USA

The possible detonation of a radiological dispersal device or improvised nuclear device in a metropolitan city, or the accidental exposures to a radiation source, nuclear accidents, or the all-to-often threats of radiological/nuclear terrorism have led to the urgent need to develop essential analytic tools to assess such radiation exposures, especially radiation doses to exposed individuals. This exposure-assessing work using biological samples, and discipline, is known as biodosimetry. As of late, this field has progressed significantly as it has made use of the advances within newer areas of biologic analytics, namely omics (genomics, proteomics, metabolomics, and transcriptomics), lymphocyte kinetics, optically stimulated luminescence, and electron paramagnetic resonance technology in addition to conventional cytogenetic techniques. The use of automated high throughput platforms and the planning for laboratory surge capacity during the time of need are the latest developments in the field of biomarkers for biodosimetry. Such biomarkers are also needed for radiation exposure/dose conversion estimates that are essential for the development and application of radiation countermeasures, from animals to humans and that are currently being developed following the US Food and Drug Administration Animal Rule. Here, we present and discuss the current status of various biomarkers for assessing radiation dose after radiation exposure. It is anticipated that with the advent of improved biomarkers and associated biomarker platforms for the acute radiation syndrome, exposed victims can be more efficiently triaged and appropriately treated than is currently allowable. The latest advances in the field, and identify the areas where improvement is needed are also listed and discussed.


How to cite this article:
Singh VK, Santiago PT, Simas M, Garcia M, Fatanmi OO, Wise SY, Seed TM. Acute radiation syndrome: An update on biomarkers for radiation injury.J Radiat Cancer Res 2018;9:132-146


How to cite this URL:
Singh VK, Santiago PT, Simas M, Garcia M, Fatanmi OO, Wise SY, Seed TM. Acute radiation syndrome: An update on biomarkers for radiation injury. J Radiat Cancer Res [serial online] 2018 [cited 2019 Sep 15 ];9:132-146
Available from: http://www.journalrcr.org/article.asp?issn=2588-9273;year=2018;volume=9;issue=4;spage=132;epage=146;aulast=Singh;type=0